March 13, 2003
Ver artículo completoTreatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
These results indicate that high-dose methotrexate is associated with modest toxicity and a radiographic response proportion (74%) comparable to more toxic regimens.